Literature DB >> 21399889

Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden.

H Strömdahl1, J Tham, E Melander, M Walder, P J Edquist, I Odenholt.   

Abstract

The aim of this study was to investigate the prevalence of extended-spectrum beta-lactamase (ESBL)-producing bacteria in patients at various hospital wards and in a group of relatively healthy volunteers, in order to obtain greater knowledge on how common these bacterial strains are in hospital settings and in the general community. Participants (n = 427) were enrolled at a University Hospital and at Primary Health Care Units (PHCUs) in Sweden in 2008 and 2010. The participants provided rectal swabs, which were tested for the occurrence of ESBL-producing bacteria. Positive samples were analysed with polymerase chain reaction (PCR) methods for bacterial strain typing and ESBL phylogroups. In 2008, the prevalence was 2.1% (2/96) in PHCU subjects and 1.8% (2/113) in hospital patients. In 2010, the prevalence was 3.0% (3/100) in PHCU subjects and 6.8% (8/118) in hospital patients. The dominating phylogroups were CTX-M-1 and CTX-M-9. All ESBL-positive isolates were Escherichia coli. We found a higher prevalence of ESBL faecal carriage than expected, both in the hospital setting and in the PHCU group.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21399889     DOI: 10.1007/s10096-011-1202-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  8 in total

Review 1.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

Authors:  Johann D D Pitout; Kevin B Laupland
Journal:  Lancet Infect Dis       Date:  2008-03       Impact factor: 25.071

2.  Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.

Authors:  J K Rasheed; C Jay; B Metchock; F Berkowitz; L Weigel; J Crellin; C Steward; B Hill; A A Medeiros; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

Review 3.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

4.  Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.

Authors:  E Lautenbach; J B Patel; W B Bilker; P H Edelstein; N O Fishman
Journal:  Clin Infect Dis       Date:  2001-03-26       Impact factor: 9.079

5.  Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.

Authors:  Johan Tham; Inga Odenholt; Mats Walder; Alma Brolund; Jonas Ahl; Eva Melander
Journal:  Scand J Infect Dis       Date:  2010-04

Review 6.  Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.

Authors:  G Kahlmeter
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

7.  Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.

Authors:  Jesús Rodríguez-Baño; Lorena López-Cerero; María D Navarro; Paula Díaz de Alba; Alvaro Pascual
Journal:  J Antimicrob Chemother       Date:  2008-07-18       Impact factor: 5.790

8.  Strama--a Swedish working model for containment of antibiotic resistance.

Authors:  S Molstad; O Cars; J Struwe
Journal:  Euro Surveill       Date:  2008-11-13
  8 in total
  19 in total

1.  Occurrence of Clinically Important Lineages, Including the Sequence Type 131 C1-M27 Subclone, among Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Wastewater.

Authors:  Ryota Gomi; Tomonari Matsuda; Yasufumi Matsumura; Masaki Yamamoto; Michio Tanaka; Satoshi Ichiyama; Minoru Yoneda
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Uropathogen distribution and antimicrobial susceptibility in uncomplicated cystitis in Belgium, a high antibiotics prescribing country: 20-year surveillance.

Authors:  S Heytens; J Boelens; G Claeys; A DeSutter; T Christiaens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-17       Impact factor: 3.267

3.  Pet animals and foreign travel are risk factors for colonisation with extended-spectrum β-lactamase-producing Escherichia coli.

Authors:  E Meyer; P Gastmeier; A Kola; F Schwab
Journal:  Infection       Date:  2012-09-13       Impact factor: 3.553

Review 4.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

5.  Faecal carriage of oxyiminocephalosporin-resistant Enterobacteriaceae among paediatric units in different hospitals in the south of France.

Authors:  A Boutet-Dubois; A Pantel; M-F Prère; O Bellon; N Brieu-Roche; E Lecaillon; A Le Coustumier; A Davin-Regli; L Villeneuve; N Bouziges; E Gleize; R Lamarca; C Dunyach-Remy; A Sotto; J-P Lavigne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-15       Impact factor: 3.267

6.  Extended-spectrum-β-lactamase-producing Escherichia coli as intestinal colonizers in the German community.

Authors:  Giuseppe Valenza; Silke Nickel; Yvonne Pfeifer; Christoph Eller; Elzbieta Krupa; Verena Lehner-Reindl; Christiane Höller
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

7.  Characteristics of Carbapenemase-Producing Enterobacteriaceae in Wastewater Revealed by Genomic Analysis.

Authors:  Ryota Gomi; Tomonari Matsuda; Masaki Yamamoto; Pei-Hsin Chou; Michio Tanaka; Satoshi Ichiyama; Minoru Yoneda; Yasufumi Matsumura
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

8.  Putative connection between zoonotic multiresistant extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in dog feces from a veterinary campus and clinical isolates from dogs.

Authors:  Katharina Schaufler; Astrid Bethe; Antina Lübke-Becker; Christa Ewers; Barbara Kohn; Lothar H Wieler; Sebastian Guenther
Journal:  Infect Ecol Epidemiol       Date:  2015-02-04

9.  Risk factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden.

Authors:  Johan Tham; Inga Odenholt; Mats Walder; Lina Andersson; Eva Melander
Journal:  Infect Drug Resist       Date:  2013-09-19       Impact factor: 4.003

10.  Antimicrobial resistance in urinary pathogens among Swedish nursing home residents remains low: a cross-sectional study comparing antimicrobial resistance from 2003 to 2012.

Authors:  Pär-Daniel Sundvall; Marie Elm; Ronny Gunnarsson; Sigvard Mölstad; Nils Rodhe; Lars Jonsson; Peter Ulleryd
Journal:  BMC Geriatr       Date:  2014-03-13       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.